… The Clinical Trials.gov databank was searched to find ongoing and completed clinical
trials evaluating the efficacy of molnupiravir against COVID- 19. The screened articles were …

… In some reports, molnupiravir has been found to reduce the … the placebo group had a
COVID-19–related hospitalization by … COVID-19 who received nirmatrelvir/ritonavir, molnupiravir, …

… In this article, we report safety, efficacy, and virology data from the phase 2, dose-finding
component of a trial evaluating molnupiravir for the treatment of Covid-19 in patients who were …

… Our study shows the efficacy and safety of molnupiravir in a real-life cohort that included a
high … to evaluate the impact of molnupiravir in the progression of COVID-19, identify the best …

… antiviral activity in patients with early COVID-19 compared with molnupiravir. Candidate
antivirals and antiviral combinations for COVID-19 should be assessed and compared using this …

… assess the efficacy and safety of molnupiravir in patients with mild or moderate COVID-19. …
thus far of the efficacy and safety of molnupiravir in treating patients with mild-to-moderate …

… trial established the efficacy and safety of molnupiravir in nonhospitalized adults with
mild to moderate COVID-19 and risk factors for progression to severe disease. Molnupiravir (800 …

… These sensitivity analyses indicated that the antiviral efficacy of molnupiravir demonstrated
in this study was not due to imbalances in seropositivity, trends in viral RNA at baseline, or …

… Here, we describe the evolution of molnupiravir (EIDD-2801, MK-4482), a broad-spectrum …
prevention and treatment of COVID-19. When the pandemic began, molnupiravir was in pre-…

… to evaluate the clinical efficacy of molnupiravir for COVID-19 patients infected with Omicron
… the antiviral efficacy between patients who were treated with molnupiravir plus basic …